15. Two symptom patterns Decreased minute ventilation Increased minute ventilation Exercise ventilation Severe oxygen desaturation, without OSA. Mild to moderate oxygen desaturation, with OSA. Nocturnal ventilation Cardiac output normal. PAP ↑ ↑ Cardiac output normal to slightly low. PAP ↑ Hemodynamics Increased perfusion to low V/Q areas Increased ventilation to high V/Q areas Special evaluations V/Q matching Total lung capacity normal or ↑ DLco normal, Static lung compliance normal Total lung capacity ↑ DLco reduced, Static lung compliance ↑ Pulmonary function tests Elevated hemoglobin. PaO 2 ↓PaCO 2 ac↑,X-ray, increased interstitial markings (“dirty lung”) Normal hemoglobin. PaO 2 ↓PaCO 2 ac↓,X-ray, hyperinflation. Laboratory studies Chronic cough, purulent sputum, overweight, peripheral edema. Age 30-40y Dyspnea, mucoid sputum, thin, chest is quiet. Age 50y History and physical examination Blue bloaters Pink puffers
27. Table 1 Points that differentiate asthma from COPD COPD Asthma History Smoker or ex-smoker Nearly all Possibly Symptoms under age 45 Uncommon Often Chronic productive cough Common Uncommon Breathlessness Persistent and progressive Variable Winter bronchitis Common Uncommon Investigations Serial PEF Obstructive picture May be normal Day to day and diurnal variation Reversibility testing Minimal variation Usually<15% or 200ml change Usually>15% or 200ml change
28.
29.
30.
31.
32.
33.
34. Table 2 Home oxygen therapy Group Ⅱ PaO 2 =56-59mmHg or S aO 2 =89% if there is evidence of any of the following 1.Dependent edema suggesting congestive heart failure 2.Pulmonary on ECG (P wave >3 mm in standard lead Ⅱ,Ⅲ, or aVF) 3.Hematocrit >56% Group Ⅰ(any of following) 1. PaO 2 ≤55mmHg or S aO 2 ≤88% taken at rest breathing room air, while awake. 2.During sleep (prescription for nocturnal oxygen use only) (1) PaO 2 ≤55mmHg or S aO 2 ≤88% for a patient whose awake ,resting, room air PaO 2 is ≥56mmHg or S aO 2 ≥89% or (2)Decrease in PaO 2 >56mmHg or decrease in S aO 2 >5% associated with symptoms or signs reasonably attributed to hypoxemia(e.g.,impaired cognitive processes,nocturnal restlessness, insomnia) 3.During exercise (prescription for oxygen use only during exercise) (1) PaO 2 ≤55mmHg or S aO 2 ≤88% taken during exercise for a patient whose awake ,resting, room air PaO 2 is ≥56mmHg or S aO 2 ≥89% and (2) There is evidence that the use of supplemental oxygen during exercise improves the hypoxemia that was demonstrated during exercise while breathing room air.
Air trapping a ffects patients with COPD. It results in an expansion of the chest wall, which places the respiratory muscles at a mechanical disadvantage. 1 Air trapping limits the ability of patients to expand tidal volume when required, for example, during activity. This makes the patient feel breathless or dyspneic. Hyperinflation, resulting from air trapping, can be observed on standard X-rays. Note the wide intercostal spaces in this patient with COPD, which are caused by air trapping. O'Donnell DE, W ebb K . The etiology of dyspnea during exercise in COPD. Pulmonary and Critical Care Update 14 , Lesson 15 .h ttp://www.chestnet.org/downloads/education/online/Vol14_13_18.pdf. Accessed 24 February 2004.